Stability of preferences with regard to adjuvant chemotherapy: impact of treatment decision, experience and the passing of time
JANSEN, S.J.T., OTTEN, W., BAAS-THIJSSEN, M.C.M., VAN DE VELDE, C.J.H., NORTIER, H.W.R., STIGGELBOUT, A.M.
Published in European journal of cancer care (01.01.2008)
Published in European journal of cancer care (01.01.2008)
Get full text
Journal Article
Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole
DE JONG, P. C, VAN DE VEN, J, NORTIER, H. W. R, MAITIMU-SMEELE, I, DONKER, T. H, THIJSSEN, J. H. H, SLEE, P. H. T. J, BLANKENSTEIN, R. A
Published in Cancer research (Chicago, Ill.) (01.06.1997)
Get full text
Published in Cancer research (Chicago, Ill.) (01.06.1997)
Journal Article
Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer
Lalisang, R I, Wils, J A, Nortier, H W, Burghouts, J T, Hupperets, P S, Erdkamp, F L, Schouten, H C, Blijham, G H
Published in Journal of clinical oncology (01.04.1997)
Published in Journal of clinical oncology (01.04.1997)
Get more information
Journal Article
Inhibition of the in vivo conversion of androstenedione to estrone by the aromatase inhibitor vorozole in healthy postmenopausal women
VAN DER WALL, E, DONKER, T. H, DE FRANKRIJKER, E, NORTIER, H. W. R, THIJSSEN, J. H. H, BLANKENSTEIN, M. A
Published in Cancer research (Chicago, Ill.) (01.10.1993)
Get full text
Published in Cancer research (Chicago, Ill.) (01.10.1993)
Journal Article